Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Metadata
Title
The Influence of Insulin Resistance, Obesity, and Diabetes Mellitus on Vascular Tone and Myocardial Blood Flow
Publication date
01-04-2012
Published in
Current Cardiology Reports / Issue 2/2012
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-011-0240-z

Other articles of this Issue 2/2012

Current Cardiology Reports 2/2012 Go to the issue

Valvular Heart Disease (V Nkomo, Section Editor)

Tricuspid Regurgitation: Pathophysiology and Management

Nuclear Cardiology (V Dilsizian, Section Editor)

Multimodality Imaging for Assessment of Myocardial Viability: Nuclear, Echocardiography, MR, and CT

Peripheral Vascular Disease (M Shishehbor, Section Editor)

Current Endovascular Management of Abdominal Aortic Aneurysm

Nuclear Cardiology (V Dilsizian, Section Editor)

The Potential Utility of 123I-mIBG in Atrial Fibrillation and in the Electrophysiology Laboratory

Peripheral Vascular Disease (M Shishehbor, Section Editor)

Carotid Artery Stenting Versus Carotid Endarterectomy: Post CREST

Peripheral Vascular Disease (M Shishehbor, Section Editor)

Current State of Diagnosis and Management of Critical Limb Ischemia

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits